Wei-Sheng Huang
Plus aucun poste en cours
Profil
Wei-Sheng Huang is the founder of Theseus Pharmaceuticals, Inc. (founded in 2017).
He also worked as a Director-Chemistry at ARIAD Pharmaceuticals, Inc. Dr. Huang completed his undergraduate degree at Huazhong University of Science & Technology and earned a doctorate degree from Shanghai Institute of Technology.
Anciens postes connus de Wei-Sheng Huang
| Sociétés | Poste | Fin |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| THESEUS PHARMACEUTICALS, INC. | Fondateur | - |
Formation de Wei-Sheng Huang
| Huazhong University of Science & Technology | Undergraduate Degree |
| Shanghai Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
